Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-08
DOI
10.1007/s00415-021-10544-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Practical Approach to Managing Patients With Myasthenia Gravis—Opinions and a Review of the Literature
- (2020) Maria Elena Farrugia et al. Frontiers in Neurology
- New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases
- (2020) Peter A.A. Norris et al. CURRENT OPINION IN HEMATOLOGY
- Chronic immunoglobulin maintenance therapy in myasthenia gravis
- (2020) M. Alcantara et al. EUROPEAN JOURNAL OF NEUROLOGY
- Myasthenia gravis
- (2019) Nils Erik Gilhus et al. Nature Reviews Disease Primers
- Stopping oral steroid-sparing agents at initiation of rituximab in myasthenia gravis
- (2019) Ricardo H. Roda et al. NEUROMUSCULAR DISORDERS
- Myasthenia gravis: State of the art and new therapeutic strategies
- (2019) Eliana B. Souto et al. JOURNAL OF NEUROIMMUNOLOGY
- Rituximab in refractory myasthenia gravis: extended prospective study results
- (2018) Grayson Beecher et al. MUSCLE & NERVE
- Burden of illness in patients with treatment refractory myasthenia gravis
- (2018) Nicole M. Engel-Nitz et al. MUSCLE & NERVE
- Immunotherapy in myasthenia gravis in the era of biologics
- (2018) Marinos C. Dalakas Nature Reviews Neurology
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- (2017) James F Howard et al. LANCET NEUROLOGY
- Rituximab as treatment for anti-MuSK myasthenia gravis
- (2017) Michael K. Hehir et al. NEUROLOGY
- Myasthenia Gravis
- (2016) Nils E. Gilhus NEW ENGLAND JOURNAL OF MEDICINE
- Myasthenia gravis: subgroup classification and therapeutic strategies
- (2015) Nils Erik Gilhus et al. LANCET NEUROLOGY
- Diagnostic and clinical classification of autoimmune myasthenia gravis
- (2014) Sonia Berrih-Aknin et al. JOURNAL OF AUTOIMMUNITY
- A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
- (2013) P. Zisimopoulou et al. JOURNAL OF AUTOIMMUNITY
- Maintenance IVIg therapy in myasthenia gravis does not affect disease activity
- (2013) M.A. Hellmann et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Newer Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- (2009) Krista Kuitwaard et al. DRUGS
- Treatment of Myasthenia Gravis Acute Exacerbations with Intravenous Immunoglobulin
- (2008) Philippe Gajdos et al. Annals of the New York Academy of Sciences
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started